Ikarian Capital »

Avrobio Ord shares owned by Ikarian Capital

Quarter-by-quarter ownership of Avrobio Ord (AVRO) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Avrobio Ord

Tip: Access up to 7 years of quarterly data

All positions including Avrobio Ord held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avrobio Ord by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $977k 718k 1.36
2023-09-30 $1.1M 718k 1.54
2023-06-30 $128k 134k 0.95
2020-09-30 $1.6M 125k 13.02

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Avrobio Ord

Atlas Venture Life Science Advisors
BML Capital Management
Newtyn Management
Vanguard Group
Aisling Capital Management
Ikarian Capital
Vazirani Asset Management
Citadel Advisors
FNY Investment Advisers
Western Standard
Two Sigma Investments
Two Sigma Advisers
Wells Fargo & Company
ADAR1 Capital Management
Barclays

View all funds holding Avrobio Ord